The article discusses the study of EP3 receptors as mediator of antinociceptive effects, referencing the study "Neuronal prostaglandin E2 receptor subtype EP3 mediates antinociception during inflammation" in the 2013 issue of "Proceedings of National Academic Science of the USA."